UniProt Q861F7
MHC class I antigen (Q861F7)
MHC class I antigen (UniProt Q861F7): 49 experimental structures on GenesisL1, 8 ligands bound, 187 pockets. Binding sites, pockets, druggability and 3D structures in GL1X.
- UniProt
- Q861F7
- Protein
- MHC class I antigen
- Experimental structures
- 49
- Predicted models
- 0
- Ligands
- 8
- Pockets
- 187 · 27 records with a druggable one
Structures
49 records of Q861F7 in the MolNFT archive: 49 experimental, 0 predicted.
| Entry | Title | Method | Chains | Ligands | Pockets |
|---|---|---|---|---|---|
| 6VR1 | Complex of HLA-A2, a class I MHC, with a p53 peptide | x-ray diffraction | A, D | — | 9 (best 0.72) |
| 6VR1 | Complex of HLA-A2, a class I MHC, with a P53 peptide | x-ray diffraction | A, D | — | — |
| 6VR5 | Complex of HLA-A2, a class I MHC, with a p53 peptide | x-ray diffraction | A, D | — | — |
| 6VR5 | Complex of HLA-A2, a class I MHC, with a P53 peptide | x-ray diffraction | A, D | — | — |
| 6VRM | T cell receptor-p53-HLA-A2 complex | x-ray diffraction | A | — | 6 (best 0.66) |
| 6VRM | T cell receptor-P53-HLA-A2 complex | x-ray diffraction | A | — | — |
| 6VRN | T cell receptor-p53-HLA-A2 complex | x-ray diffraction | A | — | 6 (best 0.68) |
| 6VRN | T cell receptor-P53-HLA-A2 complex | x-ray diffraction | A | — | — |
| 7BBG | Crystal structure of HLA-A2-WT1-rmf and Fab 11D06 | x-ray diffraction | A | NA | — |
| 7BBG | Crystal structure of HLA-A2-WT1-rmf and Fab 11D06 | x-ray diffraction | A | NA | — |
| 7KGO | Crystal Structure of HLA-A*0201in complex with SARS-CoV-2 N351-359 | x-ray diffraction | A | 3NI, CL, CD | 4 (best 0.70) |
| 7KGO | Crystal structure of HLA-A*0201IN complex with SARS-cov-2 N351-359 | x-ray diffraction | A | 3NI, CL, CD | — |
| 7KGP | Crystal Structure of HLA-A*0201 in complex with SARS-CoV-2 N316-324 | x-ray diffraction | A | CD, NA | 4 (best 0.70) |
| 7KGP | Crystal structure of HLA-A*0201 in complex with SARS-cov-2 N316-324 | x-ray diffraction | A | CD, NA | — |
| 7KGQ | Crystal Structure of HLA-A*0201in complex with SARS-CoV-2 N222-230 | x-ray diffraction | A | CD, CA | 3 (best 0.69) |
| 7KGQ | Crystal structure of HLA-A*0201IN complex with SARS-cov-2 N222-230 | x-ray diffraction | A | CD, CA | — |
| 7KGR | Crystal Structure of HLA-A*0201in complex with SARS-CoV-2 N159-167 | x-ray diffraction | A | — | 5 (best 0.69) |
| 7KGR | Crystal structure of HLA-A*0201IN complex with SARS-cov-2 N159-167 | x-ray diffraction | A | — | — |
| 7KGS | Crystal Structure of HLA-A*0201 in complex with SARS-CoV-2 N138-146 | x-ray diffraction | A | CD | 3 (best 0.70) |
| 7KGS | Crystal structure of HLA-A*0201 in complex with SARS-cov-2 N138-146 | x-ray diffraction | A | CD | — |
| 7KGT | Crystal Structure of HLA-A*0201 in complex with SARS-CoV-2 N226-234 | x-ray diffraction | A | CD, NA | 5 (best 0.68) |
| 7KGT | Crystal structure of HLA-A*0201 in complex with SARS-cov-2 N226-234 | x-ray diffraction | A | CD, NA | — |
| 7M8S | Crystal Structure of HLA-A*02:01 in complex with KLNDLCFTNV, an 10-mer epitope from SARS-CoV-2… | x-ray diffraction | A, D | — | 13 (best 0.71) |
| 7M8S | Crystal structure of HLA-A*02:01 in complex with klndlcftnv, an 10-mer epitope from SARS-cov-2… | x-ray diffraction | A, D | — | — |
| 7MJ6 | HLA-A*02:01 bound to Neuroblastoma Derived IGFBPL1 peptide | x-ray diffraction | A | — | 5 (best 0.67) |
| 7MJ6 | HLA-A*02:01 bound to neuroblastoma derived IGFBPL1 peptide | x-ray diffraction | A | — | — |
| 7MJ7 | HLA-A*02:01 bound to Neuroblastoma Derived IGFBPL1 peptide | x-ray diffraction | A | — | 5 (best 0.67) |
| 7MJ7 | HLA-A*02:01 bound to neuroblastoma derived IGFBPL1 peptide | x-ray diffraction | A | — | — |
| 7MJ8 | HLA-A*02:01 bound to Neuroblastoma Derived IGFBPL1 peptide | x-ray diffraction | A | — | 4 (best 0.68) |
| 7MJ8 | HLA-A*02:01 bound to neuroblastoma derived IGFBPL1 peptide | x-ray diffraction | A | — | — |
| 7MJ9 | HLA-A*02:01 bound to Neuroblastoma Derived mutant IGFBPL1 peptide | x-ray diffraction | A | — | 4 (best 0.68) |
| 7MJ9 | HLA-A*02:01 bound to neuroblastoma derived mutant IGFBPL1 peptide | x-ray diffraction | A | — | — |
| 7N6D | HLA peptide complex | x-ray diffraction | A, E, I, M | — | 20 (best 0.80) |
| 7N6D | HLA peptide complex | x-ray diffraction | A, E, I, M | — | — |
| 7N6E | TCR peptide HLA-A2 complex | x-ray diffraction | A, D | — | — |
| 7PBC | Crystal structure of engineered TCR (796) complexed to HLA-A*02:01 presenting MAGE-A10 9-mer peptide | x-ray diffraction | CCC | — | 6 (best 0.66) |
| 7PDW | Crystal structure of parent TCR (728) complexed to HLA-A*02:01 presenting MAGE-A10 9-mer peptide | x-ray diffraction | CCC, HHH | PO4 | 17 (best 0.75) |
| 7QPJ | Crystal structure of engineered TCR (756) complexed to HLA-A*02:01 presenting MAGE-A10 9-mer peptide | x-ray diffraction | C | — | 7 (best 0.66) |
| 7QPJ | Crystal structure of engineered TCR (756) complexed to HLA-A*02:01 presenting mage-A10 9-mer peptide | x-ray diffraction | C | — | — |
| 7RE7 | TCR mimic antibody (Fab fragment) in complex with AFP/HLA-A*02 | x-ray diffraction | A, D | — | 12 (best 0.77) |
| 7RE7 | TCR mimic antibody (Fab fragment) in complex with AFP/HLA-A*02 | x-ray diffraction | A, D | — | — |
| 7SA2 | SARS-CoV-2 spike-derived peptide S1060-1068 (VVFLHVTYV) presented by HLA-A*02:01 | x-ray diffraction | A | CD | 3 (best 0.68) |
| 7SIS | SARS-CoV-2 Spike-derived peptide S976-984 (VLNDILSRL) presented by HLA-A*02:01 | x-ray diffraction | A | CD, ZN | 4 (best 0.68) |
| 7T5M | Structure of HLA-A*02:01-FLPTPEELGLLGPPRPQVLA complex | x-ray diffraction | A, C | MG | 8 (best 0.68) |
| 8ES9 | CryoEM structure of PN45428 TCR-CD3 in complex with HLA-A2 MAGEA4 | electron microscopy | N | — | 8 (best 0.71) |
| 8FJA | CryoEM structure of HLA-A2 MAGEA4 (230-239) in complex with REGN6972 Fab | electron microscopy | A | — | 7 (best 0.69) |
| 8FJB | CryoEM structure of HLA-A2 MAGEA4 (286-294) in complex with H2aM31345N Fab | electron microscopy | A | — | 7 (best 0.80) |
| 8GOM | SARS-CoV-2 specific private TCR RLQ7 in complex with RLQ-HLA-A2 | x-ray diffraction | A | — | 6 (best 0.68) |
| 8GON | SARS-CoV-2 specific private TCR RLQ7 in complex with RLQ-T1006I-HLA-A2 | x-ray diffraction | A | — | 6 (best 0.67) |
Ligands
Elsewhere
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.